Coagulation disorders in children
Related Experiment Video
Updated: Nov 7, 2026
04:56
Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
1Division of Pediatric Hematology/Oncology, New York Hospital-Cornell Medical Center, NY 10021.
Current Opinion in Pediatrics
|February 1, 1993
Insights
Recent advancements in coagulation research highlight controversies in vitamin K prophylaxis for newborns. New insights into thrombopoiesis growth factors and the role of protein C in thrombosis are also discussed.
Area of Science:
- Hematology
- Thrombosis Research
- Pediatric Medicine
Background:
- The field of coagulation is dynamic, with ongoing research into critical aspects of hemostasis and thrombosis.
- Understanding newborn hemostasis is crucial for preventing bleeding disorders.
Purpose of the Study:
- To review significant recent developments in coagulation science.
- To highlight key areas of ongoing research and debate, including vitamin K prophylaxis, thrombopoiesis, and thrombosis.
- To synthesize current knowledge on the role of protein C in thrombotic events.
Main Methods:
- Literature review of recent publications in coagulation and thrombosis.
- Focus on key areas: vitamin K prophylaxis controversies, thrombopoiesis growth factors, and protein C in thrombosis.
- Synthesis of emerging data and established findings.
Main Results:
- Emerging controversies surround the optimal vitamin K prophylaxis for newborn infants.
- Increased understanding of growth factors regulating thrombopoiesis (platelet production) has been achieved.
- The specific role of protein C in the development of thrombosis is becoming clearer.
Conclusions:
- Vitamin K prophylaxis in newborns remains an area of active discussion and research.
- Advances in understanding thrombopoiesis offer potential therapeutic targets.
- Further elucidation of protein C's function is critical for managing thrombotic disorders.
Abstract:
Many new developments have taken place in the field of coagulation during the past year. We focus on the interesting new controversies surrounding vitamin K prophylaxis of the newborn infant, on the increasing information regarding the growth factors responsible for thrombopoiesis, and on the role of protein C in the genesis of thrombosis.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...